Insights

Strategic Focus Target hospitals and health care providers with a focus on diagnostic testing and GI indications, emphasizing WATS3D capabilities for Barrett's esophagus detection and surveillance to align with CDx Diagnostics expertise.

Technology Leverage Highlight integration capabilities with existing lab and EMR workflows using CDx Diagnostics' WATS3D data outputs, and underscore analytics and AI-assisted pathologist collaboration to improve diagnostic accuracy and throughput.

Clinical Validation Position opportunities around recent DDW data presentations and ongoing enhancements to the WATS3D test to demonstrate clinical utility, potential improvements in early cancer detection, and favorable cost-benefit profiles.

Partnership Potential Explore collaborations with midsize and large reference labs and pathology networks that resemble ARUP, NeoGenomics, or Labcorp in scale, to accelerate adoption through established distribution and service models.

Growth Signals Leverage current funding and leadership momentum to present CDx Diagnostics as a growing innovator in GI cancer screening, presenting case studies and health economics data to procurement teams seeking value-based diagnostics.

Similar companies to Cdx Laboratories

Cdx Laboratories Tech Stack

Cdx Laboratories uses 8 technology products and services including React, Envoy, Microsoft Office, and more. Explore Cdx Laboratories's tech stack below.

React
Javascript Frameworks
Envoy
Load Balancers
Microsoft Office
Office Suites
Piwik
System Analytics & Monitoring
Microsoft Teams
Team Collaboration
Google Analytics
Web Analytics
Facebook
Widgets
Twitter
Widgets

Media & News

Cdx Laboratories's Email Address Formats

Cdx Laboratories uses at least 2 format(s):

Cdx Laboratories Email Formats	Example	Percentage
FLast@cdxdiagnostics.com	JDoe@cdxdiagnostics.com	83%
LFirst@cdxdiagnostics.com	DJohn@cdxdiagnostics.com	11%
LastF@cdxdiagnostics.com	DoeJ@cdxdiagnostics.com	5%
Last@cdxdiagnostics.com	Doe@cdxdiagnostics.com	1%

Frequently Asked Questions

What is Cdx Laboratories's official website and social media links?

Cdx Laboratories's official website is cdxdiagnostics.com and has social profiles on LinkedIn.

How much revenue does Cdx Laboratories generate?

As of July 2026, Cdx Laboratories's annual revenue is estimated to be <$1M.

What is Cdx Laboratories's NAICS code?

Cdx Laboratories's NAICS code is 62 - Health Care and Social Assistance.

How many employees does Cdx Laboratories have currently?

As of July 2026, Cdx Laboratories has approximately 4 employees across 1 continents, including North America. Key team members include : A. F.: D. E.: E. R.. Explore Cdx Laboratories's employee directory with LeadIQ.

What industry does Cdx Laboratories belong to?

Cdx Laboratories operates in the Hospitals and Health Care industry.

What technology does Cdx Laboratories use?

Cdx Laboratories's tech stack includes ReactEnvoyMicrosoft OfficePiwikMicrosoft TeamsGoogle AnalyticsFacebookTwitter.

What is Cdx Laboratories's email format?

Cdx Laboratories's email format typically follows the pattern of FLast@cdxdiagnostics.com. Find more Cdx Laboratories email formats with LeadIQ.

Cdx Laboratories

Q: What is Cdx Laboratories's official website and social media links?

Cdx Laboratories's official website is cdxdiagnostics.com. Cdx Laboratories has social profiles on LinkedIn.

Q: How many employees does Cdx Laboratories have currently?

Cdx Laboratories has approximately 4 employees.

Q: What industry does Cdx Laboratories belong to?

Cdx Laboratories operates in the Hospitals and Health Care industry.

Q: What technology does Cdx Laboratories use?

Cdx Laboratories's tech stack includes Font Awesome, HSTS, Google Fonts API, Amazon Web Services, SAS.

Q: What is Cdx Laboratories's NAICS code?

Cdx Laboratories's NAICS code is 62 (Health Care and Social Assistance).

Hospitals and Health CareMassachusetts, United States2-10 Employees

In recent developments, the company has been associated with CDx Diagnostics and its WATS3D diagnostic approach for esophageal cancer screening and surveillance, including data presentations at industry conferences. These activities suggest a focus on advancing diagnostic solutions for Barrett’s esophagus and related dysplasia management, with attention to improving interpretation and accuracy through enhanced sampling and analytical techniques.